LOS ANGELES, Aug. 10, 2004 (PRIMEZONE) -- HeartSTAT Technology, Inc. (Pink Sheets:HSTA) announces that it has retained the accounting services of Bongiovanni & Associates, P.A. to complete an audit on its financial statements for the years ending December 31, 2002 and December 31, 2003 as well as a first and second quarter review ending March 31, 2004 and June 30, 2004.
Upon completion of these audited statements, HeartSTAT Technology, Inc. will immediately file its Form 10SB to the Securities and Exchange Commission and once effective will become a fully reporting company eligible to trade on the OCTBB or Nasdaq Small Cap Exchange.
About HeartSTAT Technology, Inc.
HeartSTAT Technology, Inc. and its subsidiary HeartSTAT Inc. are commercializing the first practical system for monitoring blood flow, perfusion (oxygen transport), and cardiovascular dynamics. This is a much-needed technology as physicians and other care providers are regularly misled about abnormal blood flow conditions and cardiovascular diseases.
More information on HeartSTAT Technology, Inc. (Pink Sheets:HSTA) can be found at www.HeartSTAT.com.
Statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, continued acceptance of the Company's services, increased levels of competition for the Company and dependence on the performance of the Management of the Company.